D Narsimhaswamy¹, Kurra Mohan² and Ravi Varala³*

¹12001, Belcher Rd S; Apt No: N226, Largo Florida, USA
²Department of Pharmaceutical Chemistry, Telangana University, Nizamabad, Telangana, India
³Scrips Pharma, Mallapur, Hyderabad, Telangana, India

*Corresponding Author: Ravi Varala, Scrips Pharma, Mallapur, Hyderabad, Telangana, India.

Received: November 30, 2021; Published: December 20, 2021

Abstract

This commentary briefly discusses the necessity of utilizing repurposed drugs/vaccines to combat against evil covid-19. As new variants are (such as Omicron) emerging out due to undergoing mutations by virus, urge of developing more efficient drugs is necessary both in terms of efficacy and safety.

Keywords: n-Covid; Vaccines; Efficacy; Safety; Mutations; Variants; Drugs; Repurpose

References

1. Zhu N., et al. The New England Journal of Medicine 8 (2020): 727-733.
2. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
3. Varala R., et al. Coronaviruses 1 (2020): 9-12.
4. Varala R., et al. Research Journal of Chemical Sciences 1 (2021): 84-86.
5. Varala R., et al. Caribbean Journal of Science and Technology 1 (2021): 9-12.
6. Swee Li., et al. Mini-Reviews in Medicinal Chemistry 10 (2021): 1173-1181.
7. Gokada MR., et al. Journal of Evidence-Based Integrative Medicine 26 (2021): 1-8.
8. Khan M., et al. Molecules1 (2021): 39.

Citation

Citation: Ravi Varala., et al. “n-Covid Drugs and their Relevance in Present Day Scenario". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 113-115.

Copyright

Copyright: © 2022 Ravi Varala., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.